April 25, 2019— President Trump’s ambitious campaign to end the HIV epidemic in the U.S. will rely heavily on the 340B drug pricing program, according to senior administration officials. A key focus of the effort is to connect people at risk of HIV infection to pre-exposure prophylaxis (PrEP), a treatment that can cost nearly $2,000 a month. In his State of the Union … [Read more...]
Senate Hearing Next Week on Outrageous Prescription Drug Prices
December 5, 2017—The Senate Health, Education, Labor and Pensions (HELP) Committee is holding a Dec. 12 hearing on new National Academies of Sciences (NAS) findings on why medicines cost so much and recommendations on how to fix the problem. The NAS’s Nov. 30 report is drawing attention for calling on the federal government to negotiate drugs prices with manufacturers, deny … [Read more...]
340B: A Key Part of Ending the HIV/AIDS Epidemic
Today on World AIDS Day we’re offering insight from Todd Grove, Manager of Colorado’s AIDS Drug Assistance Program. On Nov. 7, 2017, Grove gave a presentation during a congressional briefing on the 340B drug discount program’s role in fighting the HIV/AIDS epidemic. I have been living with HIV for 30 years and I guess you could call me a 340B success story. Back in the early … [Read more...]
Co-Founder of GOP Doctor’s Caucus Urges CMS To Withdraw Reimbursement Cut
October 11, 2017—The Centers for Medicare & Medicaid Services should “stand down and rescind its deleterious proposal” to slash what Medicare pays 340B hospitals for many of the most expensive medicines in use today, a co-founder of the U.S. House GOP Doctors Caucus says. In a recent commentary in the Capitol Hill newspaper The Hill, former Rep. Phil Gingrey (R-Ga.) … [Read more...]